Rare diseases
Investigational molecules
Locations
Back to Spain445 clinical trials in Galdakao, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
SpainStudy on the Effectiveness of Alteplase as an Add-On to Mechanical Thrombectomy for Patients with Acute Ischemic Stroke
SpainStudy on Brigatinib and Durvalumab for Patients with Unresectable Stage III Non-Small Cell Lung Cancer with ALK Gene Change After Chemotherapy and Radiation Therapy
SpainStudy Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
SpainStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
SpainStudy of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma
SpainStudy on the Effects of GSK3739937 for Adults with HIV-1 Who Have Not Yet Received Treatment
SpainStudy on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy
SpainStudy on Time Savings with Subcutaneous Pertuzumab and Trastuzumab for Patients with HER2-Positive Early Breast Cancer
SpainStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
SpainStudy of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients
SpainLong-Term Study on the Safety of Avalotcagene Ontaparvovec for Adults with Late-Onset Ornithine Transcarbamylase Deficiency
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on breast cancer treatments, including trials for HER2-positive and triple-negative variants. Research encompasses innovative therapies for pancreatic adenocarcinoma and colon cancer.
Multiple trials evaluating novel drug combinations and targeted therapies for improved patient outcomes.
Comprehensive research into pulmonary fibrosis and respiratory conditions, with studies examining new treatments for COPD and pulmonary embolism management.
Innovative approaches to improve lung function and patient quality of life.
Investigations into cardiomyopathy prevention and treatment, including trials for acute coronary syndromes and peripheral arterial disease management.
Focus on preventive strategies and improved treatment protocols for heart conditions.
Studies addressing endocrine disorders, including hypothyroidism and its effects. Research on hepatic conditions and smoking cessation therapies.
Diverse therapeutic approaches targeting various medical conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
